TrialFrontiers in immunology2021

Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial.

Elin Aamdal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.